Phase III Randomized, Placebo-Controlled, Double-Blind Study of Intravenous Calcium/Magnesium to Prevent Oxaliplatin- Induced Sensory Neurotoxicity, N08CB.
Intravenous calcium and magnesium prevents oxaliplatin-induced sensory neurotoxicity in adjuvant colon cancer: Results of a phase III placebo-controlled,
Intravenous Calcium and Magnesium (CaMg) Reduces Chronic, But Not Acute Neurotoxicity Associated With Oxaliplatin – Results From a Placebo- controlled.
